The pharma and biotech industry has seen an interesting cycle over the past 18 months, marked by uncertainty from organizational changes, layoffs, restructuring, and a slowdown in hiring. This trend is prompting many experienced life sciences leaders to consider stepping into independent consulting, which I believe will be part of a broader future trend towards a more flexible and mobile labor market. I had a great discussion with Marcus Metcalfe, who specializes in placing interim and freelance consultants in the biotech and pharma sectors, about this topic and my journey. I’m optimistic about 2025 and the positive opportunities it will bring for our respective businesses and the life science companies we serve.

As the 2024 business year draws to a close, I am filled with gratitude as I reflect on Pulse Edge's first year. Partnering with such an interesting array of clients on their business challenges has been a privilege and adventure. I want to extend my heartfelt thanks to everyone who placed their trust in me: clients and advisors alike. Your confidence and support have been invaluable along this journey. As a Franco-American from Boston, I’m proud to have founded a company in France that embodies a blend of global perspectives. This year I’ll be spending this holiday at home in Paris, enjoying all this beautiful city has to offer. Looking towards 2025, I am excited to explore further opportunities to empower healthcare innovators on their pathway to market access. Wishing you a wonderful holiday season filled with joy, peace and inspiration.

"𝑻𝒐 𝒂𝒔𝒌 𝒕𝒉𝒆 𝒓𝒊𝒈𝒉𝒕 𝒒𝒖𝒆𝒔𝒕𝒊𝒐𝒏 𝒊𝒔 𝒂𝒍𝒓𝒆𝒂𝒅𝒚 𝒉𝒂𝒍𝒇 𝒕𝒉𝒆 𝒔𝒐𝒍𝒖𝒕𝒊𝒐𝒏 𝒐𝒇 𝒂 𝒑𝒓𝒐𝒃𝒍𝒆𝒎." - ✨ Carl Jung In light of the upcoming Pulse Network meeting, please see the below article by myself and Jovita Balcaitiene, MD that highlights some of the global trends in the healthcare industry impacting the future for patients, as well as some critical questions as we enter 2025.

Exciting news : Pulse Network is a partner of HealthTech For Care's HealthTech Innovation Days (HTID)! This European event (Sept 17th & 18th in Paris) serves as a platform for innovation and science stakeholders. More info and register here: https://www.healthtechinnovationdays6.com/

Explore the insights from the Economist Impact’s CGT 2024 Summit, where industry experts addressed key challenges in the introduction of CGTs, including regulatory, manufacturing, supply chain, clinical, scientific, and commercial aspects. See the white paper from the events capturing important themes and takeaways from the summit, including regulatory changes and new delivery models, the need to keep conversations and practices focused on patients, and how to structure clinical trials, gather real world evidence and streamline manufacturing to help improve access to treatment.

Mid-week inspiration from Jerry Seinfeld's Duke commencement speech: I'm taking a pause to focus on "becoming" rather than "having", including a friend's prestigious award at a biopharma company, and a new project for Pulse Edge.

At the Economist Impact’s Cell and Gene Therapy (CGT) Summit last month, experts from across the industry discussed numerous topics and challenges in the introduction of CGTs: 📌 Regulatory 📌 Manufacturing and supply chain 📌 Clinical and scientific 📌 Commercial One of the major challenges facing the industry is the complexity and variability of regulatory frameworks, which can impact the development and commercialization of CGTs. Some highlights from speakers regarding 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗳𝗿𝗮𝗺𝗲𝘄𝗼𝗿𝗸𝘀.

The Economist Impact’s Cell and Gene Therapy Summit gathered international thought leaders last month in Brussels. They covered diverse themes related to a core question: 👉 How must the market evolve to sufficiently incentivize and support the development of transformative advanced therapies?

Back from a whirlwind trip to the USA, Hannah shares her thoughts on Pulse Edge and Pulse Network...over a cup of chai latte.

Great panel on empowering patients to collect their outcomes to realise value-based healthcare.

It was a pleasure reconnecting with former colleagues, making new contacts, and seeing the various minds in action during sessions yesterday.

Catch some highlights here 💫